David R. McGivern

2.8k total citations
44 papers, 2.0k citations indexed

About

David R. McGivern is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, David R. McGivern has authored 44 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hepatology, 26 papers in Epidemiology and 8 papers in Molecular Biology. Recurrent topics in David R. McGivern's work include Hepatitis C virus research (29 papers), Hepatitis B Virus Studies (16 papers) and Liver Disease Diagnosis and Treatment (13 papers). David R. McGivern is often cited by papers focused on Hepatitis C virus research (29 papers), Hepatitis B Virus Studies (16 papers) and Liver Disease Diagnosis and Treatment (13 papers). David R. McGivern collaborates with scholars based in United States, United Kingdom and Japan. David R. McGivern's co-authors include Stanley M. Lemon, Daisuke Yamane, Takahiro Masaki, Rachel Fearns, You Li, Vanessa M. Cowton, Christoph Welsch, Peter L. Collins, Lucinda Hensley and Nathaniel J. Moorman and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Immunology.

In The Last Decade

David R. McGivern

43 papers receiving 2.0k citations

Peers

Countries citing papers authored by David R. McGivern

Since Specialization

Citations

This map shows the geographic impact of David R. McGivern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. McGivern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. McGivern more than expected).

Fields of papers citing papers by David R. McGivern

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. McGivern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. McGivern. The network helps show where David R. McGivern may publish in the future.

Co-authorship network of co-authors of David R. McGivern

This figure shows the co-authorship network connecting the top 25 collaborators of David R. McGivern. A scholar is included among the top collaborators of David R. McGivern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. McGivern. David R. McGivern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Quantification of Hepatitis E Virus ORF2 Protein by a Novel Sandwich ELISA 2024 ·Viruses ·Sakthivel Subramaniam, Rafaelle Fares‐Gusmao, David R. McGivern	2
2	Distinct disease features of acute and persistent genotype 3 hepatitis E virus infection in immunocompetent and immunosuppressed Mongolian gerbils 2023 ·PLoS Pathogens ·Sakthivel Subramaniam, Rafaelle Fares‐Gusmao, Shinya Sato, John M. Cullen, Kazuyo Takeda, Patrizia Farci, David R. McGivern	10
3	Macrophage Depletion Reactivates Fecal Virus Shedding following Resolution of Acute Hepatitis A inIfnar1^–/–Mice 2022 ·Journal of Virology ·Tomoyuki Shiota, Mami Matsuda, (unknown), (unknown), Koji Ishii, Ryosuke Suzuki, Masamichi Muramatsu, Kazuhiro Takimoto, Ken‐Ichi Hanaki, Stanley M. Lemon, David R. McGivern, Asuka Hirai-Yuki	3
4	The ZCCHC14/TENT4 complex is required for hepatitis A virus RNA synthesis 2022 ·Proceedings of the National Academy of Sciences ·You Li, Ichiro Misumi, Tomoyuki Shiota, Lu Sun, Erik M. Lenarcic, (unknown), Takayoshi Shirasaki, (unknown), (unknown), (unknown), Kevin L. McKnight, Craig E. Cameron, Nathaniel J. Moorman, David R. McGivern, John M. Cullen, Jason K. Whitmire, Stanley M. Lemon	20
5	IRF3-mediated pathogenicity in a murine model of human hepatitis A 2021 ·PLoS Pathogens ·Lu Sun, You Li, Ichiro Misumi, Olga González‐López, Lucinda Hensley, John M. Cullen, David R. McGivern, Mami Matsuda, Ryosuke Suzuki, Ganes C. Sen, Asuka Hirai-Yuki, Jason K. Whitmire, Stanley M. Lemon	13
6	Stimulator of interferon genes (STING) is an essential proviral host factor for human rhinovirus species A and C 2020 ·Proceedings of the National Academy of Sciences ·Kevin L. McKnight, Karen V. Swanson, Kathryn Austgen, C A Richards, (unknown), David R. McGivern, Ethan J. Fritch, John Johnson, Katja Remlinger, Michal Magid-Slav, Maryna Kapustina, Shihyun You, Stanley M. Lemon	29
7	Evolutionary pathways to NS5A inhibitor resistance in genotype 1 hepatitis C virus 2018 ·Antiviral Research ·Shuntai Zhou, (unknown), David R. McGivern, Christina L. Burch, Fengyu Hu, (unknown), Paul Ingravallo, Ernest Asante‐Appiah, Anita Y. M. Howe, Ronald Swanstrom, Stanley M. Lemon	4
8	NLRX1 promotes immediate IRF1-directed antiviral responses by limiting dsRNA-activated translational inhibition mediated by PKR 2017 ·Nature Immunology ·Hui Feng, Erik M. Lenarcic, Daisuke Yamane, Eliane Wauthier, Jinyao Mo, Haitao Guo, David R. McGivern, Olga González‐López, Ichiro Misumi, Lola M. Reid, Jason K. Whitmire, Jenny P.-Y. Ting, Joseph A. Duncan, Nathaniel J. Moorman, Stanley M. Lemon	71
9	NS5A inhibitors unmask differences in functional replicase complex half-life between different hepatitis C virus strains 2017 ·PLoS Pathogens ·(unknown), (unknown), William Lovell, Daisuke Yamane, Petra Neddermann, Raffaele De Francesco, Stanley M. Lemon, Alan S. Perelson, Ruian Ke, David R. McGivern	15
10	Chronic hepatitis C infection–induced liver fibrogenesis is associated with M2 macrophage activation 2016 ·Scientific Reports ·Moses T. Bility, Kouki Nio, Feng Li, David R. McGivern, Stanley M. Lemon, Eoin R. Feeney, Raymond T. Chung, Lishan Su	56
11	Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle 2015 ·Journal of Virology ·David R. McGivern, Takahiro Masaki, William Lovell, C. Hamlett, (unknown), Brent Graham	32
12	miR-122 Stimulates Hepatitis C Virus RNA Synthesis by Altering the Balance of Viral RNAs Engaged in Replication versus Translation 2015 ·Cell Host & Microbe ·Takahiro Masaki, (unknown), You Li, Daisuke Yamane, David R. McGivern, Takanobu Kato, Takaji Wakita, Nathaniel J. Moorman, Stanley M. Lemon	104
13	Ribavirin Contributes to Hepatitis C Virus Suppression by Augmenting pDC Activation and Type 1 IFN Production 2015 ·PLoS ONE ·Yang Wang, David R. McGivern, Liang Cheng, Guangming Li, Stanley M. Lemon, Junqi Niu, Lishan Su, Natalia Reszka-Blanco	7
14	Kinetic Analyses Reveal Potent and Early Blockade of Hepatitis C Virus Assembly by NS5A Inhibitors 2014 ·Gastroenterology ·David R. McGivern, Takahiro Masaki, (unknown), Paul Ingravallo, Zongdi Feng, Frederick Lahser, Ernest Asante‐Appiah, Petra Neddermann, Raffaele De Francesco, A Howe, Stanley M. Lemon	84
15	Liver Injury and Disease Pathogenesis in Chronic Hepatitis C 2013 ·Current topics in microbiology and immunology ·Daisuke Yamane, David R. McGivern, Takahiro Masaki, Stanley M. Lemon	57
16	Evidence that the polymerase of respiratory syncytial virus initiates RNA replication in a nontemplated fashion 2010 ·Proceedings of the National Academy of Sciences ·Sarah L. Noton, Vanessa M. Cowton, (unknown), David R. McGivern, Rachel Fearns	31
17	Roles of the respiratory syncytial virus trailer region: Effects of mutations on genome production and stress granule formation 2010 ·Virology ·(unknown), David R. McGivern, Michael N. Teng, (unknown), Peter L. Collins, Rachel Fearns	54
18	Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core protein 2009 ·Journal of General Virology ·Allan G. N. Angus, (unknown), Steeve Boulant, David R. McGivern, R. Clayton, (unknown), Richard Adair, Sheila V. Graham, Ania M. Owsianka, Paul Targett‐Adams, (unknown), (unknown), John McLauchlan, (unknown), Arpita Patel	82
19	Hepatitis C Virus Induces E6AP-Dependent Degradation of the Retinoblastoma Protein 2007 ·PLoS Pathogens ·Tsubasa Munakata, Yuqiong Liang, Seungtaek Kim, David R. McGivern, Jon M. Huibregtse, Akio Nomoto, Stanley M. Lemon	115
20	Linear decline in serum alkaline phosphatase activity during treatment of renal osteodystrophy. 1983 ·BMJ ·Eric J. Will, M S Knapp, David R. McGivern	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact